Skip to main content

Radiation and Radioactivity

  • Chapter
  • First Online:
Thyroid Cancer

Abstract

131I therapy may result in the patient becoming a hazard to other people. When a patient treated with 131I is hospitalized, caregivers must take special precautions to protect themselves against the radiation from the 131I in the patient. When patients are released immediately or shortly after treatment, they must take precautions to protect members of the public. Special governmental regulations affect the management of patients who are treated with 131I, and the physician administering the 131I must comply with these regulations. The treating physician must communicate to the patient the risk of radiation from the 131I treatment and any special precautions the patient should take to protect others. The patient should relay the information to the patient’s family, friends, and caretakers. Communication of precautions is challenging, and patients may forget what they have been told (Ong et al., Soc Sci Med 40:903–918, 1995). A balance must be achieved in convincing the patient to agree with these specific instructions and, at the same time, dispel unnecessary fear. For this balance, the physician may need to adopt different strategies with different patients, requiring a good working knowledge of radiation and radioactivity, ionizing and nonionizing radiation, and units of radioactivity and radiation dosage. The physician must also know the regulations for hospitalization, conditions for earlier release, radiation safety precautions during hospital stay and upon release, and the myths and fears about radioactivity. This chapter presents an overview of these topics.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ong LM, de Haes JC, Hoos AM, Lammes FB. Doctor-patient communication: a review of the literature. Soc Sci Med. 1995;40:903–18.

    Article  CAS  PubMed  Google Scholar 

  2. Radiation and your patient: a guide for medical practitioners. Ann ICRP. 2001;2001:1–52.

    Google Scholar 

  3. National Research Council of the National Academies. Health effects from exposure to low levels of ionizing radiation: BEIR VII phase 2. Washington, DC: The National Academies Press; 2006.

    Google Scholar 

  4. Part 35, Medical use of byproduct material. Title 10, code of federal regulations, section 35.75.

    Google Scholar 

  5. Part G, Use of radionuclides in the healing arts. Suggested state regulations for control of radiation, vol. I, ionizing radiation. Conference of Radiation Control Program Directors. Inc.

    Google Scholar 

  6. Federal Register, 62 FR 4120, 29 Jan 1997.

    Google Scholar 

  7. Release of patients administered radioactive materials. Division 8, Occupational Health, Regulatory Guide 8.39, U.S. Nuclear Regulatory Commission, 1997. http://pbadupws.nrc.gov/docs/ML0037/ML003739575.pdf. Accessed 1 Jul 2014.

  8. Ibis E, Wilson CR, Collier BD, et al. Iodine-131 contamination from thyroid cancer patients. Nucl Med. 1992;33:2110–5.

    CAS  Google Scholar 

  9. National Council on Radiation Protection and Measurements. Ionizing radiation exposure of the population of the United States. NCRP Report No. 160; Bethesda: NCRP. 2009.

    Google Scholar 

  10. International Atomic Energy Agency. Release of patients after radionuclide therapy. IAEA safety reports series No. 63. Vienna: IAEA; 2009 http://www-pub.iaea.org/MTCD/publications/PDF/pub1417_web.pdf. Accessed 1 Jul 2014.

  11. Harolds JA. New scrutiny of outpatient therapy with I-131. Clin Nucl Med. 2011;36:206–8.

    Article  PubMed  Google Scholar 

  12. Sisson J, et al. Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I: practice recommendations of the American Thyroid Association. Thyroid. 2011;121:335–46.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Richard J Vetter PhD, CHP .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this chapter

Cite this chapter

Vetter, R.J., Glenn, J. (2016). Radiation and Radioactivity. In: Wartofsky, L., Van Nostrand, D. (eds) Thyroid Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3314-3_55

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3314-3_55

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-3312-9

  • Online ISBN: 978-1-4939-3314-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics